See more : Beryl Drugs Limited (BERLDRG.BO) Income Statement Analysis – Financial Results
Complete financial analysis of PT Nusantara Sejahtera Raya Tbk (CNMA.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Nusantara Sejahtera Raya Tbk, a leading company in the Entertainment industry within the Communication Services sector.
- Delta Lithium Limited (DLI.AX) Income Statement Analysis – Financial Results
- Kosmos Energy Ltd. (KOS.L) Income Statement Analysis – Financial Results
- Vasta Platform Limited (VSTA) Income Statement Analysis – Financial Results
- Health and Plant Protein Group Limited (HPP.AX) Income Statement Analysis – Financial Results
- Colbún S.A. (COLBUN.SN) Income Statement Analysis – Financial Results
PT Nusantara Sejahtera Raya Tbk (CNMA.JK)
About PT Nusantara Sejahtera Raya Tbk
PT Nusantara Sejahtera Raya Tbk, together with its subsidiaries, engages in the movie screening and restaurant business in Indonesia. The company operates through five segments: Cinema, Food and Beverages, Advertisement, Digital Platform, Event and Other segments. It also offers management consulting; venue rental; organizing meeting, incentives, conferences, and exhibitions activities; and event services. In addition, the company provides food and beverages; cinema services; and land leasing services; as well as m.tix and TIX. ID which provides online ticketing platform services. The company was founded in 1988 and is headquartered in Jakarta Pusat, Indonesia. PT Nusantara Sejahtera Raya Tbk operates as a subsidiary of PT Harkatjaya Bumipersada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 5,230.78B | 4,401.05B | 1,280.19B | 1,218.99B | 6,890.03B |
Cost of Revenue | 2,097.57B | 1,772.79B | 541.54B | 504.41B | 3,158.23B |
Gross Profit | 3,133.21B | 2,628.26B | 738.64B | 714.58B | 3,731.80B |
Gross Profit Ratio | 59.90% | 59.72% | 57.70% | 58.62% | 54.16% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 42.60B | 41.76B | 31.81B | 32.08B | 1,441.80B |
Selling & Marketing | 13.32B | 6.76B | 1.97B | 7.51B | 39.55B |
SG&A | 55.92B | 48.52B | 33.78B | 39.59B | 1,481.35B |
Other Expenses | 2,031.40B | 27.02B | 141.99B | 51.26B | 0.00 |
Operating Expenses | 2,087.32B | 1,911.25B | 1,093.42B | 1,304.33B | 2,078.17B |
Cost & Expenses | 4,184.89B | 3,684.04B | 1,634.96B | 1,808.74B | 5,236.40B |
Interest Income | 66.78B | 50.34B | 15.19B | 37.72B | 44.33B |
Interest Expense | 162.28B | 131.87B | 136.74B | 134.04B | 0.00 |
Depreciation & Amortization | 698.10B | 668.71B | 669.46B | 648.70B | 425.37B |
EBITDA | 1,810.77B | 1,436.06B | 328.63B | 96.67B | 2,123.33B |
EBITDA Ratio | 34.62% | 32.63% | 25.77% | 7.93% | 30.17% |
Operating Income | 1,045.89B | 717.01B | -356.01B | -589.75B | 1,653.63B |
Operating Income Ratio | 19.99% | 16.29% | -27.81% | -48.38% | 24.00% |
Total Other Income/Expenses | -95.50B | -81.53B | -121.55B | -96.33B | 44.33B |
Income Before Tax | 950.39B | 635.48B | -477.57B | -686.08B | 1,697.96B |
Income Before Tax Ratio | 18.17% | 14.44% | -37.30% | -56.28% | 24.64% |
Income Tax Expense | 208.09B | 130.94B | -111.76B | -107.20B | 423.53B |
Net Income | 687.76B | 460.38B | -351.32B | -545.74B | 1,201.31B |
Net Income Ratio | 13.15% | 10.46% | -27.44% | -44.77% | 17.44% |
EPS | 8.76 | 5.52 | -4.22 | -6.55 | 16.02 |
EPS Diluted | 8.76 | 5.52 | -4.22 | -6.55 | 16.02 |
Weighted Avg Shares Out | 78.48B | 83.35B | 83.35B | 83.35B | 75.01B |
Weighted Avg Shares Out (Dil) | 78.48B | 83.35B | 83.35B | 83.35B | 75.01B |
Source: https://incomestatements.info
Category: Stock Reports